These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23615640)

  • 1. Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women.
    Cheng G; Butler R; Warner M; Gustafsson JÅ; Wilczek B; Landgren BM
    Menopause; 2013 May; 20(5):496-503. PubMed ID: 23615640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
    Chen FP; Chien MH; Chen HY; Huang TS; Ng YT
    Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo.
    Lundström E; Hirschberg AL; Söderqvist G
    Maturitas; 2011 Dec; 70(4):361-4. PubMed ID: 21958943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of progesterone receptor membrane component 1: possible mechanism for increased breast cancer risk with norethisterone in hormone therapy.
    Neubauer H; Ruan X; Schneck H; Seeger H; Cahill MA; Liang Y; Mafuvadze B; Hyder SM; Fehm T; Mueck AO
    Menopause; 2013 May; 20(5):504-10. PubMed ID: 23615641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC
    Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of testosterone and estrogen treatment on the distribution of sex hormone receptors in the endometrium of postmenopausal women.
    Zang H; Sahlin L; Masironi B; Hirschberg AL
    Menopause; 2008; 15(2):233-9. PubMed ID: 18030175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
    Ylikorkala O; Lim P; Caubel P
    Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hormone therapy on estrogen synthesis from E1S in the mammary gland of postmenopausal women.
    Stute P; Szuwart T; Schlueter M; Götte M; Packeisen J; Kiesel L
    Maturitas; 2008 Feb; 59(2):163-73. PubMed ID: 18261865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women.
    Stuedal A; Ma H; Bjørndal H; Ursin G
    Climacteric; 2009 Jun; 12(3):248-58. PubMed ID: 19387884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
    Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
    Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method.
    Eilertsen AL; Karssemeijer N; Skaane P; Qvigstad E; Sandset PM
    BJOG; 2008 May; 115(6):773-9. PubMed ID: 18355366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestin may modify the effect of low-dose hormone therapy on mammographic breast density.
    Panoulis C; Lambrinoudaki I; Vourtsi A; Augoulea A; Kaparos G; Aravantinos L; Christodoulakos G; Creatsas G
    Climacteric; 2009 Jun; 12(3):240-7. PubMed ID: 19387881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoflavone treatment for acute menopausal symptoms.
    Cheng G; Wilczek B; Warner M; Gustafsson JA; Landgren BM
    Menopause; 2007; 14(3 Pt 1):468-73. PubMed ID: 17290160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
    Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
    Georgiev DB; Manassiev NA
    Medscape Womens Health; 2002; 7(4):1. PubMed ID: 12466733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women.
    Hofling M; Hirschberg AL; Skoog L; Tani E; Hägerström T; von Schoultz B
    Menopause; 2007; 14(2):183-90. PubMed ID: 17108847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.